Net profit of Suven Pharmaceuticals rose 77.28% to Rs 82.88 crore in the quarter ended December 2024 as against Rs 46.75 crore during the previous quarter ended December 2023. Sales rose 39.73% to Rs 307.15 crore in the quarter ended December 2024 as against Rs 219.82 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended |
| Dec. 2024 | Dec. 2023 | % Var. |
| Sales | 307.15 | 219.82 | 40 |
| OPM % | 38.32 | 30.06 | - |
| PBDT | 130.08 | 78.26 | 66 |
| PBT | 109.73 | 65.47 | 68 |
| NP | 82.88 | 46.75 | 77 |